GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (OTCPK:TSMRF) » Definitions » Other Income (Expense)

Tsumura (Tsumura) Other Income (Expense) : $23 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tsumura Other Income (Expense)?

Tsumura's other income expense for the Tsumura's pretax income for the three months ended in Mar. 2024 was $-0 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was $23 Mil.

Tsumura Other Income (Expense) Historical Data

The historical data trend for Tsumura's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura Other Income (Expense) Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.79 8.14 24.59 14.73 22.55

Tsumura Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.49 8.09 7.46 8.24 -0.37

Tsumura Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tsumura  (OTCPK:TSMRF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Tsumura (Tsumura) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (OTCPK:TSMRF) » Definitions » Other Income (Expense)
Comparable Companies
TSE:4887 TSE:4506 TSE:4547 TSE:4553 TSE:4521 TSE:4534 TSE:4551 TSE:4569 TSE:4559 TSE:4886 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
4540:Japan
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Website
http://www.tsumura.co.jp
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura (Tsumura) Headlines

From GuruFocus

Q2 2020 Tsumura & Co Earnings Presentation Transcript

By GuruFocus Research • 02-15-2024

Full Year 2019 Tsumura & Co Earnings Presentation Transcript

By GuruFocus Research • 02-15-2024